首页> 美国卫生研究院文献>Acta Naturae >Recombinant Human Butyrylcholinesterase As a New-Age Bioscavenger Drug: Development of the Expression System
【2h】

Recombinant Human Butyrylcholinesterase As a New-Age Bioscavenger Drug: Development of the Expression System

机译:重组人丁酰胆碱酯酶作为一种新型的生物清除剂:表达系统的发展。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Butyrylcholinesterase (BChE) is a serine hydrolase (EC 3.1.1.8) which can be found in most animal tissues. This enzyme has a broad spectrum of efficacy against organophosphorus compounds, which makes it a prime candidate for the role of stoichiometric bioscavenger. Development of a new-age DNA-encoded bioscavenger is a vival task. Several transgenic expression systems of human BChE were developed over the past 20 years; however, none of them has been shown to make economic sense or has been approved for administration to humans. In this study, a CHO-based expression system was redesigned, resulting in a significant increase in the production level of functional recombinant human butyrylcholinesterase as compared to the hitherto existing systems. The recombinant enzyme was characterized with Elman and ELISA methods.
机译:丁酰胆碱酯酶(BChE)是丝氨酸水解酶(EC 3.1.1.8),可在大多数动物组织中找到。该酶对有机磷化合物具有广泛的功效,这使其成为化学计量生物清除剂作用的主要候选者。开发新时代的DNA编码生物清除剂是一项艰巨的任务。在过去的20年中,已经开发了几种人BChE的转基因表达系统。但是,它们都没有被证明具有经济意义或已被批准对人类进行管理。在这项研究中,基于CHO的表达系统被重新设计,与迄今为止的现有系统相比,功能性重组人丁酰胆碱酯酶的生产水平显着提高。用Elman和ELISA方法表征重组酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号